Herbalife LTD

Herbalife announced second quarter 2026 net sales growth of 5.4% year-over-year, exceeding guidance on a constant currency basis, alongside the planned retirement of CFO John DeSimone and the appointment of Scott Schaefer.

Herbalife Ltd. announced first quarter 2026 financial results, reporting net sales growth and adjusted EBITDA above guidance, and raising full-year outlook.

Herbalife Ltd. announced the closing of an $800 million senior secured notes offering and amendments to its credit facility, refinancing existing debt and extending maturities.

Herbalife Ltd. announced preliminary Q1 2026 results, with net sales and adjusted EBITDA expected to surpass guidance, driven by strong performance in Asia Pacific.

Herbalife Ltd. reported third-quarter 2025 financial results, with net sales of $1.3 billion exceeding guidance and North America returning to year-over-year growth.

Herbalife Ltd. reported second-quarter 2025 financial results, with adjusted EBITDA exceeding guidance and a subsequent raise in full-year net sales and adjusted EBITDA outlook.

Herbalife Ltd. announced a 7.8% increase in net sales and a 22.8% rise in net income attributable to Herbalife for the first quarter of 2026.

Herbalife Ltd. reported a 2.7% increase in net sales for Q3 2025, with a significant 87.0% surge in net income for the nine-month period, driven by strategic cost reductions and pricing actions.

Herbalife Ltd. reported a significant increase in net income for Q2 2025, despite a slight decrease in net sales, driven by lower operating expenses and strategic acquisitions.

Herbalife reports a slight decrease in net sales for Q1 2025, but a significant increase in net income due to cost-cutting measures and restructuring initiatives.

Herbalife Ltd. announced its Q3 2024 results, showing a slight decrease in net sales and an increase in net income, while navigating restructuring efforts and significant debt refinancing.

Herbalife Ltd. announced its second quarter 2024 results, showing a slight decrease in net sales and a significant drop in net income, impacted by restructuring costs and debt refinancing.

Herbalife's 2024 10-K filing reveals a complex financial landscape, with net sales slightly declining amid global economic pressures and strategic shifts.

Herbalife's CEO, Michael O. Johnson, enters into a new employment agreement outlining his compensation, duties, and terms of service for 2024.

Frank Lamberti, Chief Commercial Officer of Herbalife Ltd., reported a transaction in 1,710 shares of common stock on August 4, 2026.

Herbalife Ltd. Director Sophie L'Helias purchased 1,200 shares of common stock at a price of $11.31 per share.

Herbalife Chief Operating Officer Troy Hicks reported the exercise of stock appreciation rights and subsequent sale of common shares.

Chief Commercial Officer Frank Lamberti liquidated nearly 80% of his direct holdings in Herbalife Ltd. over a two-day period in May 2026.

Herbalife Ltd. director Lynda Cloud has been granted 11,879 restricted stock units as part of the company's 2023 Stock Incentive Plan.

Herbalife Ltd. director Maria Otero received a grant of 11,879 restricted stock units as part of the company's 2023 Stock Incentive Plan.

Herbalife Ltd. announces its 2026 Annual General Meeting of Shareholders, outlining proposals for director elections, executive compensation, and auditor ratification, alongside a review of 2025 financial performance and strategic initiatives.

Herbalife Ltd. announces its 2025 Annual Meeting of shareholders, detailing proposals for director elections, executive compensation, and auditor ratification.

Herbalife Ltd. will hold its 2025 Annual General Meeting of Shareholders on April 23, 2025, to elect directors, approve executive compensation, and ratify the appointment of PricewaterhouseCoopers LLP as the company's independent auditor.

Herbalife Ltd. will hold its Annual General Meeting of Shareholders on April 25, 2024, to vote on the election of directors, executive compensation, an amendment to the stock incentive plan, and the ratification of the company's accounting firm.

Herbalife Ltd. has released its proxy statement detailing proposals for the 2024 Annual General Meeting, including the election of directors, executive compensation approval, and an amendment to the stock incentive plan.

Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation have filed a Schedule 13G, reporting beneficial ownership of 5,024,668 shares of Herbalife Ltd. common stock, representing 4.79% of the class.

FMR LLC and Abigail P. Johnson have filed an amendment to their Schedule 13G, reporting their beneficial ownership of Herbalife Ltd. common stock as of June 30, 2026.

Nantahala Capital Management, LLC has reported a 6.72% beneficial ownership stake in Herbalife Ltd. as of March 31, 2026.

FMR LLC has reported beneficial ownership of 5.3% of Herbalife Ltd's common stock as of March 31, 2026.

Vanguard Portfolio Management has reported beneficial ownership of 6,330,563 shares, representing 6.12% of Herbalife Ltd.'s common stock, as of March 31, 2026.

Vanguard Capital Management has reported beneficial ownership of 5,174,384 shares, representing 5% of Herbalife Ltd.'s common stock, as of March 31, 2026.